A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

3.7K views

⸱

DOI:

10.3791/61925

⸱

May 4th, 2021

 ,  ,  ,  , 

In This Article

Summary

Presented here is a protocol to deliver oligonucleotides such as small-interfering RNA (siRNA), micro-RNA mimics (miRs), or anti-micro-RNA (anti-miR) into mature adipocytes to modulate protein and micro-RNA expression.

Abstract

Alteration of adipocyte function contributes to the pathogenesis of metabolic diseases including Type 2 diabetes and insulin resistance. This highlights the need to better understand the molecular mechanism involved in adipocyte dysfunction to develop new therapies against obesity-related diseases. Modulating the expression of proteins and micro-RNAs in adipocytes remains highly challenging. This paper describes a protocol to differentiate murine fibroblasts into mature adipocytes and to modulate the expression of proteins and micro-RNAs in mature adipocytes through reverse-transfection using small-interfering RNA (siRNA) and micro-RNA mimicking (miR mimic) oligonucleotides. This reverse-transfection protocol involves the incubation of the transfection reagent and the oligonucleotides to form a complex in the cell culture plate to which the mature adipocytes are added. The adipocytes are then allowed to reattach to the adherent plate surface in the presence of the oligonucleotides/transfection reagent complex. Functional analyses such as the study of insulin signaling, glucose uptake, lipogenesis, and lipolysis can be performed on the transfected 3T3-L1 mature adipocytes to study the impact of protein or micro-RNA manipulation on adipocyte function.

Introduction

Obesity is considered a major risk factor for numerous metabolic diseases, including insulin resistance (IR), Type 2 Diabetes (T2D), and cardiovascular diseases1. Current therapies have failed to stop the constantly rising prevalence of these diseases, and the management of the IR of obese and diabetic patients remains an important clinical issue. Adipose tissue plays a crucial role in the control of energy homeostasis, and its pathological expansion during obesity contributes to the development of IR and T2D2,3. This highlights the need to better understand the molecular mechanism invo....

Access restricted. Please log in or start a trial to view this content.

Protocol

NOTE: Use sterile techniques to perform all the steps of the protocol in a laminar flow cell culture hood. See Table of Materials for details about all reagents and equipment.

1. Differentiation of murine 3T3-L1 fibroblasts into adipocytes

  1. Grow the 3T3-L1 fibroblasts in 100 mm dishes in culture medium-DMEM without pyruvate, 25 mM glucose, 10% newborn calf serum, and 1% penicillin and streptomycin (Figure 1A). Place the dishes in a tissue culture incubator (7% CO2 and 37 °C).
  2. Two days after confluence, change the culture medium, replacing with DMEM without p....

Access restricted. Please log in or start a trial to view this content.

Results

Using the procedure of reverse-transfection described here to modulate the expression of proteins or micro-RNAs in 3T3-L1 adipocytes, the adipocytes have been shown to preserve their morphology after the transfection (Figure 1B,C). Indeed, 2 days after the transfection, the adipocytes were well-spread and attached to the plate and presented multilocular lipid droplets that are a characteristic of mature 3T3-L1 adipocytes. The lipid content wa.......

Access restricted. Please log in or start a trial to view this content.

Discussion

This paper presents a detailed protocol for the differentiation and transfection of mature adipocytes. This reverse-transfection method is a simple, economical, and highly efficient method to transfect oligonucleotides such as, but not limited to, siRNAs, micro-RNA mimics, and anti-micro-RNAs into 3T3-L1 adipocytes, which is one of the most difficult cell lines to transfect. This method has some limitations that need to be considered. This protocol is not efficient for transfection with plasmid DNA, which limits the util.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported by INSERM, the Université Côte d'Azur, and the French National Research Agency (ANR) through the program Investments for the future Laboratory of Excellence (Labex SIGNALIFE-ANR-11-LABX-0028-01) and Initiative of Excellence (Idex UCAJEDI ANR-15-IDEX-0001). J.J. is supported by grants from the Société Francophone du Diabète (SFD), the Association Française d'Etude et de Recherche sur l'Obésité (AFERO), the Institut Thématique Multi-Organismes Technologies pour la Santé (ITMO), and the Fondation Benjamin-Delessert. J.G. is supported by ANR-18-CE14-0035-01. J-F.T. is supported by ANR gr....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
12 well Tissue Culture PlateDutscher353043
2.5% Trypsin (10x)Gibco15090-046diluted to 5x with D-PBS
2-PropanolSigmaI9516
3-Isobutyl-1-methylxanthineSigma-AldrichD5879
Accell Non-targeting PoolHorizon DiscoveryD-001910-10-05
Bovine Serum Albumin (BSA)SigmaA7030
Collagen type I from calf skinSigma-AldrichC8919
DexamethasoneSigma-AldrichD1756
D-PBSGibco14190144
Dulbecco's  Modified Eagles's Medium (DMEM)Gibco419650624.5 g/L D-Glucose; L-Glutamine; no Pyruvate
EthanolSigma51976
FAM-labeled Negative Control si-RNAInvitrogenAM4620
Fetal Bovine SerumGibco10270-106
Free Glycerol ReagentSigma-AldrichF6428
Glycerol Standard SolutionSigma-AldrichG7793
HSP90 antibodySanta Cruzsc-131119Dilution : 0.5 µg/mL
Improved Minimal Essential Medium (Opti-MEM)Gibco31985-047
Insulin, Human RecombinantGibco12585-014
miRIDIAN micro-RNA mimicsHorizon Discovery
miRNeasy Mini KitQiagen217004
miScript II RT KitQiagen218161
miScript Primer Assays Hs_RNU6-2_11QiagenMS00033740
miScript Primer Assays Mm_miR-34a_1QiagenMS00001428
miScript SYBR Green PCR KitQiagen219073
Newborn Calf SerumGibco16010-159
Oil Red OSigmaO0625
ON-TARGETplus Mouse Plin1 si-RNA SMARTpoolHorizon DiscoveryL-056623-01-0005
Penicillin and StreptomycinGibco15140-122
Perilipin-1 antibodyCell Signaling3470Dilution : 1/1000
Petri dish 100 mm x 20 mmDutscher353003
PKB antibodyCell Signaling9272Dilution : 1/1000
PKB Phospho Thr308 antibodyCell Signaling9275Dilution : 1/1000
RosiglitazoneSigma-AldrichR2408
Transfection reagent (INTERFERin)Polyplus409-10
α-tubulin antibodySigma aldrichT6199Dilution : 0.5 µg/mL
Vamp2 antibodyR&D SystemsMAB5136Dilution : 0.1 µg/mL

References

  1. Klöting, N., et al. Insulin-sensitive obesity. American Journal of Physiology, Endocrinology and Metabolism. 299 (3), 506-515 (2010).
  2. Weyer, C., Foley, J. E., Bogardus, C., Tataranni, P. A., Pratley, R. E.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Adipocyte DifferentiationReverse TransfectionsiRNA TransfectionmiRNA Mimic3T3-L1 AdipocytesInsulin SignalingGlucose UptakeLipolysis AssayLipogenesis AssayCollagen Coating